1 |
Jantas, D., Greda, A., Golda, S., Korostynski, M., Grygier, B., Roman, A., Pilc, A. and Lason, W. 2014. Neuroprotective effects of metabotropic glutamate receptor group II and III activators against -induced cell death in human neuroblastoma SH-SY5Y cells: the impact of cell differentiation state. Neuropharmacology 83, 36-53.
DOI
|
2 |
Lee, B., Cao, R., Choi, Y. I., Cho, H. E., Rhee, A. D., Hah, C. K., Hoyt, K. R. and Obrietan, K. 2009. The CREB/CRE transcriptional pathway: protection against oxidative stressmediated neuronal cell death. J. Neurochem. 108, 1251-1265.
DOI
|
3 |
Li, J., O, W., Li, W., Jiang, Z. G. and Ghanbari, H. A. 2013. Oxidative stress and neurodegenerative disorders. Int. J. Mol. Sci. 14, 24438-24475.
DOI
|
4 |
Lin, Y. L., Wang, G. J., Huang, C. L., Lee, Y. C., Liao, W. C., Lai, W. L., Lin, Y. J. and Huang, N. K. 2009. Ligusticum chuanxiong as a potential neuroprotectant for preventing serum deprivation-induced apoptosis in rat pheochromocytoma cells: functional roles of mitogen-activated protein kinases. J. Ethnopharmacol. 122, 417-423.
DOI
|
5 |
Lonze, B. E. and Ginty, D. D. 2002. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623.
DOI
|
6 |
Lonze, B. E., Riccio, A., Cohen, S. and Ginty, D. D. 2002. Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 34, 371-385.
DOI
|
7 |
Lu, S., Lu, C., Han, Q., Li, J., Du, Z., Liao, L. and Zhao, R. C. 2011. Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation. Toxicology 279, 189-195
DOI
|
8 |
Mattson, M. P. 2000. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell. Biol. 1, 120-129.
DOI
|
9 |
Mu, X., Yuan, X., Du, L. D., He, G. R. and Du, G. H. 2016. Antagonism of quercetin against tremor induced by unilateral striatal lesion of 6-OHDA in rats. J. Asian Nat. Prod. Res. 18, 65-71.
DOI
|
10 |
Mukai, R., Kawabata, K., Otsuka, S., Ishisaka, A., Kawai, Y., Ji, Z. S., Tsuboi, H. and Terao, J. 2012. Effect of quercetin and its glucuronide metabolite upon 6-hydorxydopamineinduced oxidative damage in Neuro-2a cells. Free Radic. Res. 46, 1019-1028.
DOI
|
11 |
Murakami, A., Ashida, H. and Terao, J. 2008. Multitargeted cancer prevention by quercetin. Cancer Lett. 269, 315-325.
DOI
|
12 |
Oliver, F. J., de la Rubia, G., Rolli, V., Ruiz-Ruiz, M. C., de Murcia, G. and Mnissier-de Murcia, J. 1998. Importance of poly (ADP-ribose) polymerase and its cleavage in apoptosis Lesson from an uncleavable mutant. J. Biol. Chem. 273, 33533-33539.
DOI
|
13 |
Oltvai, Z. N. and Korsmeyer, S. J. 1994. Check points of dueling dimers foil death wishes. Cell 79, 189-192.
DOI
|
14 |
Ossola, B., Kaariainen, T. M. and Mannisto, P. T. 2009. The multiple faces of quercetin in neuroprotection. Expert Opin. Drug Saf. 8, 397-409.
DOI
|
15 |
Perez, A., Gonzalez-Manzano, S., Jimenez, R., Perez-Abud, R., Haro, J. M., Osuna, A., Santos-Buelga, C., Duarte, J. and Perez-Vizcaino, F. 2014. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity. Pharmacol. Res. 89, 11-18.
DOI
|
16 |
Perez-Vizcaino, F., Duarte, J., Jimenez, R., Santos-Buelga, C. and Osuna, A. 2009. Antihypertensive effects of the flavonoid quercetin. Pharmacol. Rep. 61, 67-75.
DOI
|
17 |
Chun, H. S., Gibson, G. E., DeGiorgio, L. A., Zhang, H., Kidd, V. J. and Son, J. H. 2001. Dopaminergic cell death induced by , oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76, 1010-1021.
DOI
|
18 |
Pu, X., Song, Z., Li, Y., Tu, P. and Li, H. 2003. Acteoside from Cistanche salsa inhibits apoptosis by 1-methyl-4-phenylpyridinium ion in cerebellar granule neurons. Planta Med. 69, 65-66.
DOI
|
19 |
Baral, S., Pariyar, R., Kim, J., Lee, H. S. and Seo, J. 2017. Quercetin-3-O-glucuronide promotes the proliferation and migration of neural stem cells. Neurobiol. Aging 52, 39-52.
DOI
|
20 |
Carlezon Jr, W. A., Duman, R. S. and Nestler, E. J. 2005. The many faces of CREB. Trends Neurosci. 28, 436-445.
DOI
|
21 |
Comalada, M., Camuesco, D., Sierra, S., Ballester, I., Xaus, J., Galvez, J. and Zarzuelo, A. 2005. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kB pathway. Eur. J. Immunol. 35, 584-592.
DOI
|
22 |
Costa, L. G., Garrick, J. M., Roque, P. J. and Pellacani, C. 2016. Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more. Oxid. Med. Cell. Longev. 2016, 2986796.
|
23 |
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y. and Greenberg, M. E. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241.
DOI
|
24 |
Du, K. and Montminy, M. 1998. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273, 32377-32379.
DOI
|
25 |
Gu, X., Liu, L., Shen, Q. and Xing, D. 2017. Photoactivation of ERK/CREB/VMAT2 pathway attenuates MPP+-induced neuronal injury in a cellular model of Parkinson's disease. Cell Signal. 37, 103-114.
DOI
|
26 |
Fearnley, J. M. and Lees, A. J. 1991. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283-2301.
DOI
|
27 |
Fernandes-Alnemri, T., Litwack, G. and Alnemri, E. S. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. 269, 30761-30764.
DOI
|
28 |
Forno, L. S. 1996. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259-272.
DOI
|
29 |
Itano, Y. and Nomura, Y. 1995. 1-methyl-4-phenyl-pyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SHSY5Y cells, through different mechanisms. Brain Res. 704, 240-245.
DOI
|
30 |
Wang, H., Xu, J., Lazarovici, P., Quirion, R. and Zheng, W. 2018. cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of Schizophrenia. Front. Mol. Neurosci. 11, 255.
DOI
|
31 |
Wang, Y., Gao, J., Miao, Y., Cui, Q., Zhao, W., Zhang, J. and Wang, H. 2014. Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway. J. Mol. Neurosci. 53, 537-545.
DOI
|
32 |
Saura, C. A. and Valero, J. 2011. The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev. Neurosci. 22, 153-169.
DOI
|
33 |
Weng, Z., Signore, A. P., Gao, Y., Wang, S., Zhang, F., Hastings, T., Yin, X. M. and Chen, J. 2007. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J. Biol. Chem. 282, 34479-34491.
DOI
|
34 |
Zhang, C., Yuan, X., Hu, Z., Liu, S., Li, H., Wu, M., Yuan, J., Zhao, Z., Su, J. and Wang, X. 2017. Valproic acid protects primary dopamine neurons from -induced neurotoxicity. Biomed. Res. Int. 2017, 8124501.
|
35 |
Zhu, J. H., Horbinski, C., Guo, F., Watkins, S., Uchiyama, Y. and Chu, C. T. 2007. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am. J. Pathol. 170, 75-86.
DOI
|